YR
Yasmeen Rahimi Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
22
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $3 |
126%
upside
| 1 | -10% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $25 |
182%
upside
| 1 | -13% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $23 |
151%
upside
| 1 | +38% |
0
%
| 13 Feb ‘26 2 months ago |
|
|
|
Overweight
Upgraded
| $30 |
108%
upside
| 1 | +8.3% |
0
%
| 29 Jan ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $1,200 |
250%
upside
| 1 | -3.5% |
0
%
| 28 Jan ‘26 2 months ago |
|
|
|
Overweight
Initiated
| $15 |
99%
upside
| 1 | +49% |
0
%
| 28 Jan ‘26 2 months ago |
|
|
|
Overweight
Initiated
| $73 |
295%
upside
| 1 | +20% |
0
%
| 27 Jan ‘26 2 months ago |
|